Head to head
Glucagon against Survodutide
Glucagon raises blood sugar, which is why adding its receptor to a weight loss drug looks counterintuitive until you see what it does to liver fat and energy expenditure. This pair sets the hormone next to a dual agonist built to use it.
Column A
GlucagonGlucagon (pancreatic hormone)
The hormone that raises blood sugar, FDA-approved as an emergency treatment for severe hypoglycemia and a target of the newest dual and triple agonists.
Column B
SurvodutideSurvodutide (GLP-1 / glucagon dual agonist)
An investigational once-weekly GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.
Side by side, on the facts we can check
| Attribute | Glucagon | Survodutide |
|---|---|---|
| Category | Metabolic | Metabolic |
| FDA status | FDA-approved for severe hypoglycemia | Investigational, not FDA-approved |
| Half-life | ~8-18 minutes | ~6 days |
| Molecular weight | 3,482.8 Da | ~4,900 Da |
| Mechanism | Activates glucagon receptors, chiefly in the liver, to raise blood glucose and increase energy expenditure and hepatic fat oxidation. | Agonizes both GLP-1 and glucagon receptors, combining appetite suppression and improved glucose handling with increased energy expenditure and hepatic fat reduction. |
| Human studies cited | 2 | 3 |
| Legal status, US | FDA-approved, prescription only | Investigational, not approved |
Frequently asked questions
What is the difference between Glucagon and Survodutide?
Glucagon: The hormone that raises blood sugar, FDA-approved as an emergency treatment for severe hypoglycemia and a target of the newest dual and triple agonists. Survodutide: An investigational once-weekly GLP-1 and glucagon receptor dual agonist studied for obesity and metabolic liver disease.
Which has stronger research evidence, Glucagon or Survodutide?
This database does not grade compounds. It counts what was run in people: 2 of the 4 studies cited on the Glucagon profile were human work, against 3 of 3 for Survodutide. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.
Are Glucagon and Survodutide FDA-approved?
Glucagon: FDA-approved for severe hypoglycemia. Survodutide: Investigational, not FDA-approved.
Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.